Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
about
Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantationCytochrome P450 in living donor liver transplantation.Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
P2860
Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact of donor and recipient ...... ish liver transplant patients.
@en
Impact of donor and recipient ...... ish liver transplant patients.
@nl
type
label
Impact of donor and recipient ...... ish liver transplant patients.
@en
Impact of donor and recipient ...... ish liver transplant patients.
@nl
prefLabel
Impact of donor and recipient ...... ish liver transplant patients.
@en
Impact of donor and recipient ...... ish liver transplant patients.
@nl
P2093
P2860
P50
P356
P1476
Impact of donor and recipient ...... ish liver transplant patients.
@en
P2093
Francisco Suarez
José Antonio Pons
José María Alamo
Magdalena Salcedo
Miguel Angel Gómez-Bravo
Olga Millán
Sebastián Rufian
P2860
P304
P356
10.1002/JCPH.154
P577
2013-09-11T00:00:00Z